Retail Clinics

PRINCETON, N.J., and WILMINGTON, Del. — The makers behind a popular Type 2 diabetes treatment have included data from two clinical studies in an update to the drug's prescribing information.

Bristol-Myers Squibb and AstraZeneca said the Food and Drug Administration approved the labeling update for Onglyza (saxagliptin), which now includes efficacy and safety information about the drug's effects on patients with renal impairment or end-stage renal disease.

ANN ARBOR, Mich. — A convenient blood-glucose test commonly used to diagnose diabetes and prediabetes may not be the best way to diagnose children, according to a new study.

MONROVIA, Calif. — Biotab Nutraceuticals on Tuesday initiated a voluntary recall of two lots of Extenze nutritional supplement tablets.

Some packages bearing lot numbers 0709241 and 0509075 are counterfeit products containing undeclared drug ingredients that can pose a serious risk to health, the company stated.

MOUNTAIN VIEW, Calif. — LifeScience Plus recently introduced Advanced BloodStop, a bandage that helps stop bleeding in less than one minute, at CVS/pharmacy.

“We are very excited to be able to offer this product through CVS,” stated Wayne Korteweg, COO of LifeScience Plus. “BloodStop is so much more effective and versatile than ordinary bandages; it’s an essential for any medicine cabinet, first aid kit or car for home or travel emergencies.”

ST. PAUL, Minn. — Zipnosis, which offers online access to mainstream medicine by providing consumers with simple and convenient online diagnosis and treatment of common health needs, and Park Nicollet Health Services have announced a new initiative with Resource Training and Solutions that will bring online health care to people living in central Minnesota.

LITTLE ROCK, Ark. — Arkansas on Friday became the fourth state this year to entertain making the popular decongestant pseudoephedrine available only by prescription.

NEW YORK — In line with American Heart Month, Boehringer Ingelheim's Micardis has introduced a cardiovascular risk-reduction calculator, designed to assess patients' cardiovascular risk.

The calculator, which can be accessed at MicardisPro.com, is an interactive, useful tool for healthcare professionals to assist patients in reaching their cardiovascular risk-reduction goal, the company said.

Micardis (telmisartan) is a drug designed to treat hypertension.

NEW YORK — A new Harris Poll published Tuesday suggested that many doctors are doing little or nothing to help their overweight patients to lose weight.

Using classifications defined by the World Health Organization, 19% of those who are morbidly obese (with a body mass index of 35 or greater), 46% of those who are obese (BMI of between 30 and 34) and 72% who are overweight but not obese (BMI of between 25 and 29), said that their doctors have never told them to lose weight.